Eli Lilly has just received the first ever FDA-approval for a cluster headaches treatment. Christi Shaw, President of Bio-Medicines at Eli Lilly, joined Cheddar to discuss the difficulties that people with Horton's syndrome suffer and the development that went into Emgality.